logo
Share SHARE
FONT-SIZE Plus   Neg

Urologix CEO Stryker Warren To Retire

Urologix, Inc. (ULGX) said Tuesday that Stryker Warren jr. has decided to retire as CEO and a member of the company's Board of Directors, effective November 30.

The company said its Chief Operating Officer Greg Fluet will become interim CEO following Warren's retirement.

Fluet joined the company as its Executive Vice President and Chief Operating Officer in July 2008. Prior to joining Urologix, he was an Associate at Sapient Capital Management, LLC, a venture capital firm focused on medical devices.

Warren came out of retirement to join Urologix as CEO in June 2008. He had previously been the President and CEO of Urology Healthcare Group whose wholly owned subsidiary, Urotech, remains Urologix' largest customer.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Sony announced Project Field, a new play way to bring card games to life, along with a host of smartphone games at an event in Japan, aiming to accelerate mobile drive. Project Field is a Japan-only card collection platform where actual physical cards will work with a smartphone app. The first title to be announced is based on Yo-kai Watch for mobile. There is no news about an international releas Shares of Credit Suisse Group AG gained around 8 percent in the morning trading in Zurich after the Swiss banking giant raised its group cost savings target, and also confirmed its medium-term 2018 pre-tax income target. It is almost the end of the year. With the exception of a few, many of the biotech stocks, like the following, on which investors had bet big this year have served up only heartbreak. Now, let's take a look at some of the pending clinical trial catalysts of this month, which will make it a December to remember.
comments powered by Disqus
Follow RTT